We feel that the de-regulation of pharmacy services may curtail services and in effect reduce patient care, as has been the case in the United States, just at a time when the role of the pharmacist in the promotion of primary, secondary and tertiary care has been identified as an important element in the provision of future diabetes patient care in this country.